Synexus tries out a sales force for patient recruitment
This article was originally published in Scrip
The clinical trials patient recruitment firm Synexus is pioneering a new concept in the UK, a "GP sales force", which will visit doctors and encourage them to enter patients in clinical trials in partnership with it.
You may also be interested in...
Denmark’s biotech Genmab has dropped the AXL targeted antibody-drug conjugate, enapotamab vedotin from early clinical development, and is focusing its resources on other therapeutic programs.
Pipeline Watch is a weekly snapshot of selected late-stage clinical trial events and approvals announced by pharmaceutical and biotech companies at medical and industry conferences, in financial and company presentations, and in company releases and statements.
European biotech Pharvaris has received series C funding to support its novel potential therapy for hereditary angioedema, in a competitive sector of drug development.